MYD88 and type 2 diabetes mellitus: It is interesting that neither genetic nor pharmacologic inhibition of MyD88 affected hyperglycemia in mice with T1D or T2D, indicating that the cardiac benefits observed in T1D and T2D mice were mainly due to the anti‐inflammatory effect of MyD88 inhibition.